In a filing, Aquestive Therapeutics Inc revealed its Chief Innovation/Tech Officer Schobel Alexander Mark unloaded Company’s shares for reported $0.3 million on Mar 15 ’24. In the deal valued at $6.00 per share,50,000 shares were sold. As a result of this transaction, Schobel Alexander Mark now holds 984,476 shares worth roughly $3.88 million.
Then, Schobel Alexander Mark sold 25,000 shares, generating $129,685 in total proceeds. Upon selling the shares at $5.19, the Chief Innovation/Tech Officer now owns 1,040,371 shares.
Piper Sandler initiated its Aquestive Therapeutics Inc [AQST] rating to an Overweight in a research note published on April 11, 2024; the price target was $10. A number of analysts have revised their coverage, including Raymond James’s analysts, who began to cover the stock in late March with a ‘”an Outperform”‘ rating. H.C. Wainwright started covering the stock on April 22, 2019. It rated AQST as “a Buy”.
Price Performance Review of AQST
On Monday, Aquestive Therapeutics Inc [NASDAQ:AQST] saw its stock jump 0.77% to $3.94. Over the last five days, the stock has lost -3.19%. Aquestive Therapeutics Inc shares have risen nearly 95.05% since the year began. Nevertheless, the stocks have risen 231.09% over the past one year. While a 52-week high of $6.23 was reached on 03/18/24, a 52-week low of $1.12 was recorded on 01/02/24. SMA at 50 days reached $3.88, while 200 days put it at $2.36. A total of 1.34 million shares were traded, compared to the trading of 3.51 million shares in the previous session.
Levels Of Support And Resistance For AQST Stock
The 24-hour chart illustrates a support level at 3.81, which if violated will result in even more drops to 3.69. On the upside, there is a resistance level at 4.08. A further resistance level may holdings at 4.23. The Relative Strength Index (RSI) on the 14-day chart is 44.73, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.00%. Stochastics %K at 25.00% indicates the stock is a holding.
The most recent change occurred on January 03, 2019 when Lake Street began covering the stock and recommended ‘”a Buy”‘ rating along with a $14 price target.
